register

Market Research & Insights

What high-performing MedTech companies are doing differently

Health Industry Hub | January 11, 2021 |
[Total: 1    Average: 4/5]

Market Research & Insights: Innovation and product development (I&PD) in the MedTech sector is costly.

A strong I&PD strategy can help MedTech companies drive greater market share and offer value to patients and customers. The key is delivering the right products to the market at the right time.

Deloitte collected data from 14 MedTech companies to understand each organisation’s I&PD spending allocation and performance on key metrics. They looked at:

  1. Predictability – How good the company was at achieving its goals for product development projects?
  2. Revenue contribution – How much new products contributed to the revenue of the company over time?

Key findings

Top performance neither depends on the types of products a company develops nor the markets it participates in, but instead on how it allocates its spending and manages its product development.

According to the 2020 Deloitte findings, the top MedTech companies:

  1. Increased focus on transformational products: Top-performing companies reported allocating nearly twice the amount of R&D budget to transformational products as other companies. This indicates that these companies are actively investing in being innovation leaders in the market in order to drive higher growth.
  2. Higher spending on front-end market understanding: Top performers allocated nearly twice the amount of investment in front-end market research than the average. Just as investing in early technical de-risking improves predictability, high-performing companies appear to be investing in understanding the market to de-risk the investments in market-leading transformation products.
  3. Less focus on sustaining products: Top performing MedTech organisations spent only a third of their budget on sustaining products compared to companies with lower transformational product revenue, signalling a shift in attention from existing products toward innovation.

What else is helping top performers stand out?

Top-performing Medtech companies do not overload their development pipelines, thus resulting in a more focused allocation of their resources and increased overall productivity.

The top-performing companies also use emerging practices such as agile development methodologies and advanced IT development tools to support engineering and clinical development. Many companies have used agile for software development for years, but MedTech companies have generally been slower to adopt these methods. This is likely based on the misplaced belief that they are incompatible with the risk and regulatory requirements of medical devices. In some cases, the use of these practices by leading companies was focused on accelerating the cycles of early development experimentation to help improve predictability, and in other cases, to accelerate the integration of digital technologies into their product portfolio transformation efforts. Leading companies have, in some cases, even understood how to appropriately adopt these practices into hardware innovation.

The road ahead for MedTech I&PD leaders

  • Engage leadership across functions (both business and technical): I&PD is often the most cross-functional activity within an organisation. Having cross-functional leadership alignment on company performance is vital to future improvement success.
  • Prioritise performance improvement goals: MedTech leaders should align their appetite for improvement with the level of change they are willing to create. Using comparative data can help guide an organisation to areas that are truly underperforming. It can be easy to “want it all” but not be willing to match the level of change effort needed to achieve the goals. The bigger the goals, the broader and deeper the changes in business practices may need to be.
  • Be honest and objective about what business practices you are actually employing: Many organisations may have solid business practices on paper, but their organisational behaviour does not live up to those practices.
  • Don’t reinvent the wheel: If a company’s benchmarking data demonstrates a significant gap in a performance metric, they can look at other companies that are already using practices to close that gap. Seeking assistance in understanding those practices and how quickly it might be possible to deploy them can be beneficial.
  • Be open to truly leading practices: Emerging practices such as agile methodologies come from outside the MedTech industry. Similarly, advances in information technology in I&PD support systems such as simulation, automation, and clinical evidence generation can open the door to implementing practices that were not operationally viable previously. However, adoption of leading practices depends on how well they can be linked to performance improvement objectives, not just because they seem new and different.

About the author

About the author

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nam luctus finibus scelerisque. Nunc bibendum ipsum sed augue fringilla fringilla. Nullam at consectetur leo. Praesent viverra rutrum porta. Quisque vitae mi vel purus vulputate tincidunt. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Suspendisse et mi quis nisi rhoncus feugiat at ac tellus. Sed aliquam sodales nulla ac auctor. Sed pretium lobortis purus accumsan ullamcorper. Phasellus sodales vel odio in lobortis. Duis maximus sagittis bibendum. Interdum et malesuada fames ac ante ipsum primis in faucibus. Nunc dictum tincidunt ipsum in vestibulum. Donec ut sem consectetur, aliquam quam vitae, pharetra orci. Nam egestas non velit eu rhoncus. Duis congue neque non lacus tincidunt porta. Vestibulum ultricies pulvinar sem, molestie congue dui aliquet non.
  • Ut imperdiet leo id lorem fermentum consectetur.
  • Ut vitae orci et dui varius tincidunt.
  • Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Aliquam erat volutpat. Vestibulum vitae varius diam. Nulla eget congue ante. Nunc ullamcorper sagittis augue vel dictum. Mauris finibus nibh ut pulvinar auctor. Vestibulum ut faucibus nisi. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Quisque porta tortor ac justo malesuada elementum. Nulla tellus ante, cursus nec ex sit amet, suscipit bibendum arcu. Duis posuere orci dui, et mollis enim dictum at. Sed ullamcorper, sapien ut vulputate viverra, sem purus porttitor tellus, nec mattis mauris ligula sed risus. Nulla sagittis id ipsum eu mattis. Link to full profile

Leadership & Management

Leadership Management Qualities - The power of being an authentic leader

The power of being an authentic leader

Health Industry Hub | April 21, 2021 |

Leadership & Management: Welcome to Health Industry Hub’s Women in Leadership Series – connecting, engaging and empowering women in the […]

More


Digital & Innovation

Healthcare Technology Digital Innovations - Data is the biggest challenge, and opportunity, for MedTech

Data is the biggest challenge, and opportunity, for MedTech

Health Industry Hub | April 21, 2021 |

Digital & Innovation: Medical technology is increasingly shaping the future of healthcare. The sector is also a growing part of […]

More


News & Trends - Medical Technology

MedTech News - Thermo Fisher acquisition to better serve its pharma and biotech clients

Thermo Fisher acquisition to better serve its pharma and biotech clients

Health Industry Hub | April 21, 2021 |

MedTech News: Thermo Fisher Scientific is buying clinical research services provider PPD for a hearty $17.4 billion, and that’s not its only acquisition this […]

More


News & Trends - Pharmaceuticals

Pharma News - First-in-class oncology drug candidate licensed by Aussie pharma

First-in-class oncology drug candidate licensed by Aussie pharma

Health Industry Hub | April 21, 2021 |

Pharma News: An Australian oncology-focused drug development company entered into a worldwide exclusive licensing agreement and a master services agreement […]

More